Gene Expression of CYP1A1 and its Possible Clinical Application in Thyroid Cancer Cases

Background: Thyroid cancer is the most common endocrine malignancy, and exact causes remain unknown. The role of CYP450 1A1 (CYP1A1) in cancer initiation and progression has been investigated. The aim of this work was to analyze, for the first time, CYP1A1 gene expression and its relationship with s...

Full description

Saved in:
Bibliographic Details
Published inAsian Pacific journal of cancer prevention : APJCP Vol. 17; no. 7; pp. 3477 - 3482
Main Authors Gallegos-Vargas, JA, Sanchez-Roldan, J, Ronquillo-Sanchez, MD, Carmona-Aparicio, L, Floriano-Sanchez, E, Cardenas-Rodriguez, N
Format Journal Article
LanguageKorean
Published 2016
Subjects
Thyroid cancer
cytochrome P450 1A1
molecular marker
Online AccessGet full text

Cover

More Information
Summary:Background: Thyroid cancer is the most common endocrine malignancy, and exact causes remain unknown. The role of CYP450 1A1 (CYP1A1) in cancer initiation and progression has been investigated. The aim of this work was to analyze, for the first time, CYP1A1 gene expression and its relationship with several clinicopathological factors in Mexican patients diagnosed with thyroid cancer. Materials and Methods: Real-time PCR analysis was conducted on 32 sets of thyroid tumors and benign pathologies. Expression levels were tested for correlations with clinical and pathological data. All statistical analysis were performed using GraphPad Prism version 3.0 software. Results: We found that female gender was associated with thyroid cancer risk (P<0.05). A positive relationship was identified between CYP1A1 mRNA levels and the presence of chronic disease, alcohol use, tumor size, metastasis and an advanced clinical stage (P<0.05). Conclusions: The results suggest that CYP1A1 gene expression could be used as a marker for thyroid cancer.
Bibliography:KISTI1.1003/JNL.JAKO201617847602182
ISSN:1513-7368
2476-762X